Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis

• Published in: Molecular biology (New York) Vol. 46; no. 3; pp. 421 - 432
• Main Authors: Davalieva, K., Kiprijanovska, S., Broussard, C., Petrusevska, G., Efremov, G. D.
• Format: Journal Article
• Language: English
• Published: Dordrecht SP MAIK Nauka/Interperiodica 01.05.2012; Springer Nature B.V
• Subjects: Aged; Biochemistry; Biomarkers; Biomarkers, Tumor - genetics; Biomedical and Life Sciences; Breast cancer; Breast Neoplasms - diagnosis; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Carcinoma, Ductal, Breast - diagnosis; Carcinoma, Ductal, Breast - genetics; Carcinoma, Ductal, Breast - pathology; Electrophoresis, Gel, Two-Dimensional; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Human Genetics; Humans; Hydrogen-Ion Concentration; Life Sciences; Middle Aged; Molecular biology; Molecular Biomedicine Special Issue; Neoplasm Invasiveness; Neoplasm Proteins - genetics; Oncology; Protein Interaction Mapping; Proteins; Proteome - analysis; Proteome - genetics; Proteomics; Tandem Mass Spectrometry; Tumors; breast cancer; biomarker; MS/MS; 2-D DIGE; infiltrating ductal carcinoma
• ISSN: 0026-8933; 0026-8984; 1608-3245
• DOI: 10.1134/S0026893312030053

There is a growing interest in protein expression profiling aiming to identify novel diagnostic markers in breast cancer. Proteomic approaches such as two-dimensional differential gel electrophoresis coupled with tandem mass spectrometry analysis (2-D DIGE/MS/MS) have been used successfully for the identification of candidate biomarkers for screening, diagnosis, prognosis and monitoring of treatment response in various types of cancer. Identifying previously unknown proteins of potential clinical relevance will ultimately help in reaching effective ways to manage the disease. We analyzed breast cancer tissues from five tumor and five normal tissue samples from ten breast cancer subjects with infiltrating ductal carcinoma (IDC) by 2-D DIGE using two types of immobilized pH gradient (IPG) strips: pH 3–10 and pH 4–7. From all the spots detected, differentially expressed ( p < 0.05 and ratio > 2) were 50 spots. Of these, 39 proteins were successfully identified by MS, representing 29 different proteins. Ten proteins were overexpressed in the tumor samples. The 2-D DIGE/MS/MS analysis revealed an increase in the expression levels in tumor samples of several proteins not previously associated with breast cancer, such as: macrophage-capping protein (CAPG), phosphomannomutase 2 (PMM2), ATPase ASN1, methylthioribose-1-phosphate isomerase (MRI1), peptidyl-prolyl cis-trans isomerase FKBP4, cellular retinoic acid-binding protein 2 (CRABP2), lamin B1 and keratin, type II cytoskeletal 8 (KRT8). Ingenuity Pathway Analysis (IPA) revealed highly significant ( p = 10 −26 ) interactions between the identified proteins and their association with cancer. These proteins are involved in many diverse pathways and have established roles in cellular metabolism. It remains the goal of future work to test the suitability of the identified proteins in samples of larger and independent patient groups.